Behavioural disorders Mental and Behavioural Disorders Hyperkinetic disorders
Conditions
Interventions
1. Methylphenidate (MPH) treatment
2. No methylphenidate treatment
Sponsors
NHS R&D Regional Programme Register - Department of Health (UK)
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 60 boys aged between 7-12 years, receiving MPH, with a diagnosis of Hyperkinetic disorder or the equivalent ADHD combined sub-type, will be recruited from out-patient psychiatric clinics in the Trent region.
Exclusion criteria
Exclusion criteria: Does not match inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Information about effects of MPH on cognitive function (including the possibility of cognitive toxicity) in children with ADHD 2. Greater understanding of the underlying cognitive processes in ADHD This knowledge of underlying mechanisms will lead to improved specificity of early detection, diagnosis and treatment of ADHD 3. Identification of potential cognitive deficits in ADHD. If persisting cognitive deficits are identified. These will be rational targets for supplementary treatment interventions 4. Suggestion of tests to monitor the effects of MPH on cognitive function which could be developed for use in everyday clinical practice. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed